Back to search
Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor trials you may qualify forA phase I/II study of PI3Kinase inhibition (copanlisib) and anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in mismatch-repair…
This is an open-label, non-randomized, Phase 1b/2 study to determine the safety and tolerability of NC410 when combined with a standard dose of pembrolizumab. T…